Mendelian randomization is a commonly used causal inference method with some obvious advantages. First, it can provide more reliable and accurate causal inferences than traditional observational studies[7]. Mendelian randomization can eliminate potential confounding factors, reverse causal effects and reduce the misleading results commonly seen in observational studies by taking advantage of the random natural allocation of genes.[15] Second, Mendelian randomized analysis can effectively avoid selection bias in the study. In traditional observational studies, due to the voluntary connection between exposure and outcome, individual selective behavior may lead to a correlation between outcome and exposure, thus generating bias. Mendelian randomization can eliminate this bias and provide more reliable results[16]. In this study, we used this approach to explore the causal relationship between ankylosing spondylitis and common andrological conditions using a pooled data set from genome-wide association studies. The risk of male infertility in patients with AS is 2.389 times higher than that in the normal population, and the risk of prostatic hyperplasia is correspondingly increased.
The results from the MR‒Egger and weighted median methods were not significant. The values of IVW and MR‒Egger QP for heterogeneity analysis were greater than 0.05, indicating that there was no significant heterogeneity for the included SNPs, and the result p for pleiotropic analysis was greater than 0.05, indicating that there was no horizontal pleiotropic effect for exposure factors and outcome variables. The sensitivity analysis was performed using the leave-one-out method, and no significant effect of SNP loci in any tool variable was found on the results, indicating that the results were highly reliable.
Ankylosing spondylitis is generally occult; at present, the cause of the disease is not completely clear and mainly includes genetic factors, inflammation and some infection factors (common infection lesions in ankylosing spondylitis patients are mainly in the upper respiratory tract, gastrointestinal tract, and genitourinary tract, and ankylosing spondylitis-related common pathogenic bacteria are Klebsiella pneumoniae, mycoplasma, chlamydia, etc.)、 endocrine factors (the occurrence of ankylosing spondylitis is closely related to internal environment disorders caused by the sex hormone immune response and abnormal metabolites). and immune factors, etc[17–20]. Pathogenesis mainly includes abnormal expression or misfolding of HLA-B27, joint peptide hypothesis, primary abnormality of ERAP pruning function, intestinal immunity, and other factors[21]. Progression of ankylosing spondylitis should be prevented. Nonsteroidal anti-inflammatory drugs are the first-line therapy, and tumor necrosis factor-α antagonists can be applied for treatment if the disease is aggravated[22]. At the same time, they can be combined with acupuncture treatment with a significant effect. Infection prevention is also needed in daily life.
Male infertility is usually caused by one or more causes or diseases and is therefore complex. It includes primary infertility and secondary infertility[23]. Male infertility is related to many factors. According to the survey, we believe that the most likely cause of male infertility is mainly endogenous (such as oxidative stress and sperm chromatin damage) and exogenous (such as environmental pollution, male reproductive tract infection, urinary system diseases, some inflammation, electromagnetic radiation and automobile exhaust). Some idiopathic causes include idiopathic abnormal semen parameters, idiospermia, etc[24–30]. The treatment principles for male infertility include the age of the spouse, multi-experience treatment, and the technique of using drugs first and test-tube baby second. There is currently a lack of systematic medication plans for the medical treatment of male infertility. It mainly includes hormone drugs, anti-infection treatment, levocarnitine treatment, antioxidant treatment, treatment to improve reproductive system microcirculation, and Chinese medicine treatment[31, 32].
Benign prostatic hyperplasia (BPH) is a common disease of the urinary system and is common in middle-aged and elderly people. The clinical manifestations of BPH include frequent micturition, urgent urination, strenuous urination, nocturia and dribbling urine[33]. The pathogenesis of BPH is caused by a variety of factors. Age and testis function are clear factors for the occurrence and development of BPH. Metabolic disorders caused by MS also play an aggravating role in the development of BPH. In addition, the occurrence of the disease is closely related to residents' increasingly poor lifestyle, dysfunctional diet (such as smoking, drinking, exercising, animal protein intake is less or high and intake of fat is too high), and no sexual activity[34, 35]. If BPH does not cause more obvious obstruction, usually no treatment is needed. Medication is available for patients with minor obstruction or surgical intolerance; surgical treatment can be performed in patients with severe urination obstruction and residual urine volume exceeding 50 mL or in patients who induce complications for which pharmacological treatment is not effective. Common drug therapies mainly include α1-AR antagonists, 5α-reductase inhibitors, phosphodiesterase 5 inhibitors, and plant preparations. Surgical treatments include transurethral resection of the prostate with bipolar plasma vaporization, transurethral incision of the prostate, and transurethral enucleation of the prostate[36].
Patients with AS are generally at risk for decreased sperm motility and increased incidence of sperm aneuploidy[37, 38]. Chatzimeletiou et al.[39] Semen analysis of patients with AS by light, electron and fluorescence microscopy revealed a high incidence of sperm head, neck and tail abnormalities, with low aneuploidy levels for all chromosomes tested. At the same time, combined with previous studies, he concluded that inflammation in patients with AS seemed to be related to impaired testicular function. Javier et al[6] observed that in untreated male patients with hypogonadism, hypogonadism itself and very low serum testosterone levels are associated with an increase in AS frequency. As shown in the experimental results by a handful of scholars, testosterone or its metabolites regulate the balance of immune function by affecting the inhibition of NK cell proliferation, T-cell count and CD8 + activity. Low testosterone levels may lead to abnormal immune function, thus increasing the probability of ankylosing spondylitis. Therefore, in consideration of the above aspects, there may be a potential mechanism by which the serum-free testosterone level can be used as an index for predicting the immune ability status of the body.
However, there are also scholars whose results are quite different. Gordon et al[40]. Thirty-three patients with AS were evaluated and found to have lost fertility in only one patient. Nukumizu et al[41]. Minimal sperm abnormalities were observed in 20 patients with AS, and effects on male fertility are considered to be empirically substantiated. Almeida et al[42] found that there was no significant difference in the levels of sex hormones and semen analysis between the 20 patients with AS and the 24 healthy control groups. Therefore, determining the association between the two needs further experimental verification.
However, there were some potential biases and limitations in this study that need to be noted. First, the Mendelian randomization method assumes that gene variation is completely random for exposure, which may not be true in some cases. For example, the results may be affected if genetic variation is associated with other potential confounding factors. Second, the European population is the subject of the GWAS data study, and therefore, there are differences at the gene level, and it is uncertain whether this result applies to other populations. Third, the GWAS data extracted in this study lacked hierarchical analysis on age, disease course, and other aspects, so an in-depth study of specific information was not possible. Last, the data on male infertility and BPH used in this paper are insufficient for further analysis of outcome variables due to a lack of clinical data.
In summary, in this study, ankylosing spondylitis was used as the exposure factor, and significantly related SNPs were selected as the instrumental variables. IVW, Mr. Egger 's regression and WME were used for analysis. Sensitivity analysis did not find pleiotropicity or heterogeneity. The results showed that patients with ankylosing spondylitis had an increased risk of male infertility and prostatic hyperplasia, and it was suggested that patients with ankylosing spondylitis should pay attention to the prevention and treatment of male infertility and prostatic hyperplasia. At the same time, scholars can expand the research and improve the direction on this basis, expecting to find new causal mechanisms related to male infertility and BPH and providing new treatment perspectives for clinicians and new ideas for the prevention and treatment of male infertility and BPH.